Inhibition of phosphorolysis catalyzed by HIV-1 reverse transcriptase is responsible for the synergy found in combinations of 3'-azido-3'-deoxythymidine with nonnucleoside lnhibitors

被引:21
|
作者
Cruchaga, C
Odriozola, L
Andréola, M
Tarrago-Litvak, L
Martínez-Irujo, JJ
机构
[1] Univ Navarra, Dept Bioquim & Biol Mol, Pamplona 31008, Spain
[2] Univ Bordeaux 2, CNRS, UMR 5097, IFR66 Pathol Infect & Canc, F-33076 Bordeaux, France
关键词
D O I
10.1021/bi048129z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In spite of the growing attention to the combined chemotherapy in the treatment of AIDS, the molecular mechanisms underlying the antiviral synergy of combinations of reverse transcriptase (RT) inhibitors are in most cases unknown. Most combinations of nonnucleoside inhibitors (NNRTI) with nucleoside analogues synergistically inhibit HIV-1 replication in cell culture, though they fail to show synergy in enzymatic assays. In this work we have examined the mechanisms mediating the synergy in combinations of AZTTP with NNRTIs on HIV-1 RT and their possible relevance in antiretroviral therapy. We found that if two inhibitors bind either to different sites on the RT or to the same site but to different mechanistic forms, it is always possible to find conditions in which their combination results in synergistic inhibition of DNA polymerase activity. Though these analyses are interesting from a biochemical point of view, this kind of synergy is unlikely to play any role in vivo, since this positive interaction is lost under the conditions present in viral replication. Here we describe that the synergy found for combinations of NNRTI with AZT is due not to the inhibition of the DNA polymerase activity but to the inhibition of the RT-catalyzed phosphorolysis by the NNRTI. While phosphorolytical removal of the AZT-terminated primer has been related to the mechanism of resistance toward AZT, our data suggest that a basal phosphorolysis occurs even with the wild-type enzyme, and that the inhibition of this activity could explain the synergy found in antiviral assays.
引用
收藏
页码:3535 / 3546
页数:12
相关论文
共 50 条
  • [1] Mutations in the connection domain of HIV-1 reverse transcriptase increase 3′-azido-3′-deoxythymidine resistance
    Nikolenko, Galina N.
    Delviks-Frankenberry, Krista A.
    Palmer, Sarah
    Maldarelli, Frank
    Fivash, Matthew J., Jr.
    Coffin, John M.
    Pathak, Vinay K.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (01) : 317 - 322
  • [2] Inhibition of the initiation of HIV-1 reverse transcription by 3′-azido-3′-deoxythymidine -: Comparison with elongation
    Rigourd, M
    Lanchy, JM
    Le Grice, SFJ
    Ehresmann, B
    Ehresmann, C
    Marquet, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (35) : 26944 - 26951
  • [3] INHIBITION OF THE REVERSE-TRANSCRIPTASE FROM HIV BY 3'-AZIDO-3'-DEOXYTHYMIDINE TRIPHOSPHATE AND ITS THREO ANALOG
    VRANG, L
    BAZIN, H
    REMAUD, G
    CHATTOPADHYAYA, J
    OBERG, B
    [J]. ANTIVIRAL RESEARCH, 1987, 7 (03) : 139 - 149
  • [4] CONFORMATIONAL PROPERTIES OF 3'-AZIDO-3'DEOXYTHYMIDINE (AZT), AN INHIBITOR OF HIV REVERSE-TRANSCRIPTASE
    HERZYK, P
    BEVERIDGE, A
    NEIDLE, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 145 (03) : 1356 - 1361
  • [5] Non-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3′-azido-3′-deoxythymidine (AZT)-resistant polymerase to AZT-5′-triphosphate
    Odriozola, L
    Cruchaga, C
    Andréola, M
    Dollé, V
    Nguyen, CH
    Tarrago-Litvak, L
    Pérez-Mediavilla, A
    Martínez-Irujo, JJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) : 42710 - 42716
  • [6] SYNTHESIS AND HIV-1 REVERSE-TRANSCRIPTASE INHIBITION PROPERTIES OF 2 NEW METHYLENEPHOSPHONATE ANALOGS OF 3'-AZIDO-3'-DEOXYTHYMIDINE-5'-TRIPHOSPHATE
    LABATAILLE, P
    PELICANO, H
    MAURY, G
    IMBACH, JL
    GOSSELIN, G
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (20) : 2315 - 2320
  • [7] 3′-azido-3′-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes
    Ren, JS
    Esnouf, RM
    Hopkins, AL
    Jones, EY
    Kirby, I
    Keeling, J
    Ross, CK
    Larder, BA
    Stuart, DI
    Stammers, DK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9518 - 9523
  • [8] INHIBITION OF 3'AZIDO-3'DEOXYTHYMIDINE-RESISTANT HIV-1 INFECTION BY DEHYDROEPIANDROSTERONE IN-VITRO
    YANG, JY
    SCHWARTZ, A
    HENDERSON, EE
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (03) : 1424 - 1432
  • [9] The 3′-azido group is not the primary determinant of 3′-azido-3′-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1
    Sluis-Cremer, N
    Arion, D
    Parikh, U
    Koontz, D
    Schinazi, RF
    Mellors, JW
    Parniak, MA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (32) : 29047 - 29052
  • [10] INHIBITION OF HIV-1 TRANSMISSION BY INTERFERON AND 3'-AZIDO-3'-DEOXYTHYMIDINE DURING DENOVO INFECTION OF PROMONOCYTIC CELLS
    DUBREUIL, M
    SPORTZA, L
    DADDARIO, M
    LACOSTE, J
    ROOKE, R
    WAINBERG, MA
    HISCOTT, J
    [J]. VIROLOGY, 1990, 179 (01) : 388 - 394